Unknown

Dataset Information

0

Sialidosis type II: Expansion of phenotypic spectrum and identification of a common mutation in seven patients.


ABSTRACT: Sialidosis, an autosomal recessive disorder, is characterized by progressive lysosomal storage of sialylated glycopeptides and oligosaccharides. It occurs as a result of biallelic mutations in the NEU1 gene. Sialidosis is traditionally classified as a milder, late-onset type I and a severe early-onset type II disease. The presence of a cherry-red spot is a well-established ophthalmological clue to the disorder. We present a clinical-radiological report of seven unrelated patients with molecularly confirmed sialidosis type II. To the best of our knowledge, This is the largest reported series of patients with Sialidosis type II. A novel, previously unreported ophthalmic phenotype of bulls-eye maculopathy, is described. All seven phenotypically heterogeneous patients had the same pathogenic variant (c.679G > A; p.Gly227Arg) at a homozygous level in the NEU1 gene. We propose that this is a common mutation in north Indians for this rare disorder. We also observed an overlap of symptoms and a continuum of phenotypes in type I and II Sialidosis.

SUBMITTER: Arora V 

PROVIDER: S-EPMC6957780 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sialidosis type II: Expansion of phenotypic spectrum and identification of a common mutation in seven patients.

Arora Veronica V   Setia Nitika N   Dalal Ashwin A   Vanaja Maria Celestina MC   Gupta Deepti D   Razdan Tinku T   Phadke Shubha R SR   Saxena Renu R   Rohtagi Anshu A   Verma Ishwar C IC   Puri Ratna Dua RD  

Molecular genetics and metabolism reports 20200111


Sialidosis, an autosomal recessive disorder, is characterized by progressive lysosomal storage of sialylated glycopeptides and oligosaccharides. It occurs as a result of biallelic mutations in the <i>NEU1</i> gene. Sialidosis is traditionally classified as a milder, late-onset type I and a severe early-onset type II disease. The presence of a cherry-red spot is a well-established ophthalmological clue to the disorder. We present a clinical-radiological report of seven unrelated patients with mol  ...[more]

Similar Datasets

| S-EPMC6751914 | biostudies-literature
| S-EPMC4521068 | biostudies-literature
| S-EPMC8490189 | biostudies-literature
| S-EPMC9981418 | biostudies-literature
| S-EPMC2638801 | biostudies-literature
| S-EPMC8856904 | biostudies-literature
| S-EPMC4864711 | biostudies-other
| S-EPMC8307306 | biostudies-literature
| S-EPMC5025718 | biostudies-literature
| S-EPMC6186933 | biostudies-literature